Early blood plasma transfusion reduces mortality in patients with severe bleeding. It is therefore important to ensure availability of blood plasma at all treatment levels, including prehospital health services. This can be achieved by use of dried plasma.
We are looking for collaborators that can develop technology to produce dried plasma. Dried plasma is a scarce resource, so local production is important to secure availability and preparedness both locally and nationally.
Invitation to Innovation partnership: Local production of dried blood plasma for delivery to Bergen Hospital Trust.
Information regarding the procurement is available on Ted - tenders electronic daily (Supplement to the Official Jpurnal of the EU)
Production of dried plasma at the blood banks will enable a stable supply of a life-saving product. In addition, we will have the flexibility to adjust the production to needs in an emergency.
A dialogue conference was held in Bergen 23rd of August 2022 (in norwegian). The aim was to invite stakeholders in the market who wish to participate in the development of a system for drying blood plasma used for the treatment of patients with life-threatening bleeding.